ADMA Biologics Inc (ADMA)
Pretax margin
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 73,356 | 39,172 | -3,050 | -28,240 | -22,827 | -40,292 | -47,686 | -65,905 | -70,322 | -73,135 | -78,275 | -71,647 | -74,406 | -73,610 | -74,883 | -75,748 | -66,901 | -61,422 | -54,456 | -48,279 |
| Revenue (ttm) | US$ in thousands | 382,809 | 330,245 | 283,177 | 258,216 | 234,293 | 208,108 | 181,890 | 154,079 | 130,481 | 110,072 | 93,998 | 80,944 | 68,517 | 58,112 | 48,069 | 42,220 | 40,301 | 37,248 | 36,021 | 29,350 |
| Pretax margin | 19.16% | 11.86% | -1.08% | -10.94% | -9.74% | -19.36% | -26.22% | -42.77% | -53.89% | -66.44% | -83.27% | -88.51% | -108.59% | -126.67% | -155.78% | -179.41% | -166.00% | -164.90% | -151.18% | -164.49% |
September 30, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $73,356K ÷ $382,809K
= 19.16%
The pretax margin of ADMA Biologics Inc has fluctuated significantly over the past few years. From December 2019 to September 2020, the company experienced negative pretax margins ranging from -179.41% to -151.18%, indicating that its expenses exceeded its earnings before taxes during this period.
However, there seems to have been a notable improvement in financial performance starting from December 2020, as the pretax margin gradually increased to 19.16% by September 2024. This positive trend suggests that the company may have implemented cost-cutting measures or improved revenue generation strategies that have led to stronger profitability.
It is essential to monitor ADMA Biologics Inc's pretax margin closely in the future to assess the sustainability of this upward trajectory and to ensure the company maintains a healthy level of profitability.
Peer comparison
Sep 30, 2024